At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.

This article focuses on the emerging role of social workers in advancing psilocybin-assisted therapy as a novel treatment for major depressive disorder (MDD) and substance use disorder (SUD). It highlights clinical evidence demonstrating psilocybin's significant and lasting therapeutic effects, including rapid symptom reduction in MDD and promising outcomes in reducing SUD relapse rates, often after just one or two doses. The U.S. Food and Drug Administration (FDA) has designated psilocybin as a "breakthrough therapy," and legislative efforts to legalize its therapeutic use are increasing across multiple states. The article emphasizes the ethical and practical responsibilities of social workers to engage in research, advocacy, policy development, and clinical implementation of psilocybin-assisted therapy, particularly ensuring equitable access for marginalized populations and integrating culturally informed practices.